a cost-benefit analysis of haemophilus influenzae type b disease preventive strategies was updated to consider evaluation of the h. influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine ( prp-d ) and h. influenzae type b oligosaccharide-mutant diphtheria toxin conjugate vaccine ( hboc ) for children at 18 months of age .
C0032594
polysaccharide
C0028959
oligosaccharide